Literature DB >> 18350453

Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment.

Rima Shalom1, Sofia Rimbroth, Dganit Rozenman, Arie Markel.   

Abstract

Hyperuricemia is present in approximately 5% of the population. The vast majority is asymptomatic and at no clinical risk. Allopurinol, an analog of hypoxanthine, has been widely used in clinical practice for more than 30 years for the treatment of hyperuricemia and gout. Two percent of patients develop a mild exanthema when on this drug, which usually resolves after withdrawal of the drug. A syndrome characterized by exfoliative dermatitis, hepatitis, interstitial nephritis, and eosinophilia, termed allopurinol hypersensitivity syndrome, has been described, and its etiology related to the accumulation of one of allopurinol's metabolites, oxypurinol, of which clearance is decreased in the setting of renal insufficiency and the use of thiazide diuretics. The term DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Syndrome has been recently used to describe an entity presenting with similar features.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350453     DOI: 10.1080/08860220701861045

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  8 in total

Review 1.  DRESS syndrome: a case report and literature review.

Authors:  Cláudia Sofia Cardoso; Ana Margarida Vieira; Ana Paula Oliveira
Journal:  BMJ Case Rep       Date:  2011-06-03

Review 2.  Characterizing DRESS syndrome recurrence: a systematic review.

Authors:  Ajay N Sharma; Samantha Shwe; Vignesh Ravi; Melanie Miller; Natasha A Mesinkovska; Nathan W Rojek; Scott Worswick
Journal:  Arch Dermatol Res       Date:  2021-09-10       Impact factor: 3.033

3.  DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?

Authors:  Zahrae Sandouk; Zaid Alirhayim; Dania Khoulani; Syed Hassan
Journal:  BMJ Case Rep       Date:  2012-11-14

Review 4.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.

Authors:  Marwan H Adwan
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.686

5.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

Review 6.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

7.  Evaluation of the Antihyperuricemic Activity of Phytochemicals from Davallia formosana by Enzyme Assay and Hyperuricemic Mice Model.

Authors:  Chen-Yu Chen; Chi-Chang Huang; Keng-Chang Tsai; Wei-Jan Huang; Wen-Ching Huang; Yu-Chen Hsu; Feng-Lin Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-04       Impact factor: 2.629

8.  Successful treatment of drug reaction with eosinophilia and systemic symptoms syndrome relapse with oral pulsed dexamethasone.

Authors:  Claire-Audrey Y Bayan; Adriana Lopez; Natalia M Fontecilla; Larisa J Geskin
Journal:  JAAD Case Rep       Date:  2018-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.